Akili, Inc. launched EndeavorOTC, a video game therapy for attention deficit/hyperactivity disorder (ADHD) in adults, at the inaugural Digital Therapeutics Alliance Summit in Washington, DC on 7 June.
EndeavorOTC is based on the same technology as Akili's EndeavorRx therapy for children. The US Food and Drug Administration authorized EndeavorRx in 2020 to treat symptoms of ADHD in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?